726 related articles for article (PubMed ID: 27984730)
1. Naturally Occurring Off-Switches for CRISPR-Cas9.
Pawluk A; Amrani N; Zhang Y; Garcia B; Hidalgo-Reyes Y; Lee J; Edraki A; Shah M; Sontheimer EJ; Maxwell KL; Davidson AR
Cell; 2016 Dec; 167(7):1829-1838.e9. PubMed ID: 27984730
[TBL] [Abstract][Full Text] [Related]
2. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
3. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins.
Zhu Y; Gao A; Zhan Q; Wang Y; Feng H; Liu S; Gao G; Serganov A; Gao P
Mol Cell; 2019 Apr; 74(2):296-309.e7. PubMed ID: 30850331
[TBL] [Abstract][Full Text] [Related]
4. Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis.
Rousseau BA; Hou Z; Gramelspacher MJ; Zhang Y
Mol Cell; 2018 Mar; 69(5):906-914.e4. PubMed ID: 29456189
[TBL] [Abstract][Full Text] [Related]
5. Phage-Encoded Anti-CRISPR Defenses.
Stanley SY; Maxwell KL
Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
[TBL] [Abstract][Full Text] [Related]
6. The Anti-CRISPR Story: A Battle for Survival.
Maxwell KL
Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
[TBL] [Abstract][Full Text] [Related]
7. Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein.
Hoffmann MD; Mathony J; Upmeier Zu Belzen J; Harteveld Z; Aschenbrenner S; Stengl C; Grimm D; Correia BE; Eils R; Niopek D
Nucleic Acids Res; 2021 Mar; 49(5):e29. PubMed ID: 33330940
[TBL] [Abstract][Full Text] [Related]
8. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of inhibition of CRISPR-Cas9 by anti-CRISPR protein AcrIIC1.
Zhu Y; Yin S; Li Z
Biochem Biophys Res Commun; 2023 Apr; 654():34-39. PubMed ID: 36878037
[TBL] [Abstract][Full Text] [Related]
10. Anti-CRISPR AcrIIC3 discriminates between Cas9 orthologs via targeting the variable surface of the HNH nuclease domain.
Kim Y; Lee SJ; Yoon HJ; Kim NK; Lee BJ; Suh JY
FEBS J; 2019 Dec; 286(23):4661-4674. PubMed ID: 31389128
[TBL] [Abstract][Full Text] [Related]
11. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2.
Thavalingam A; Cheng Z; Garcia B; Huang X; Shah M; Sun W; Wang M; Harrington L; Hwang S; Hidalgo-Reyes Y; Sontheimer EJ; Doudna J; Davidson AR; Moraes TF; Wang Y; Maxwell KL
Nat Commun; 2019 Jun; 10(1):2806. PubMed ID: 31243272
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CRISPR-Cas9 with Bacteriophage Proteins.
Rauch BJ; Silvis MR; Hultquist JF; Waters CS; McGregor MJ; Krogan NJ; Bondy-Denomy J
Cell; 2017 Jan; 168(1-2):150-158.e10. PubMed ID: 28041849
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the anti-CRISPR, AcrIIC4.
Kim GE; Lee SY; Park HH
Protein Sci; 2021 Dec; 30(12):2474-2481. PubMed ID: 34676610
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4.
Li X; Liao F; Gao J; Song G; Zhang C; Ji N; Wang X; Wen J; He J; Wei Y; Zhang H; Li Z; Yu G; Yin H
Nucleic Acids Res; 2023 Sep; 51(17):9442-9451. PubMed ID: 37587688
[TBL] [Abstract][Full Text] [Related]
16. Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing.
Bolukbasi MF; Liu P; Luk K; Kwok SF; Gupta A; Amrani N; Sontheimer EJ; Zhu LJ; Wolfe SA
Nat Commun; 2018 Nov; 9(1):4856. PubMed ID: 30451839
[TBL] [Abstract][Full Text] [Related]
17. Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins.
Hoffmann MD; Aschenbrenner S; Grosse S; Rapti K; Domenger C; Fakhiri J; Mastel M; Börner K; Eils R; Grimm D; Niopek D
Nucleic Acids Res; 2019 Jul; 47(13):e75. PubMed ID: 30982889
[TBL] [Abstract][Full Text] [Related]
18. Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing.
Garcia B; Lee J; Edraki A; Hidalgo-Reyes Y; Erwood S; Mir A; Trost CN; Seroussi U; Stanley SY; Cohn RD; Claycomb JM; Sontheimer EJ; Maxwell KL; Davidson AR
Cell Rep; 2019 Nov; 29(7):1739-1746.e5. PubMed ID: 31722192
[TBL] [Abstract][Full Text] [Related]
19. Structural Investigation of Self-Assembly and Target Binding of Anti-CRISPR AcrIIC2.
Kim Y; Lee SJ; Park C; Koo J; Bae E; Lee BJ; Suh JY
CRISPR J; 2021 Jun; 4(3):448-458. PubMed ID: 34042500
[TBL] [Abstract][Full Text] [Related]
20. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish.
Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B
Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]